EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-13-0781
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Novel Function of EpCAM in Oral Squamous Cell Carcinoma Cells Under Anchorage-Independent Conditions

International Journal of Oncology
Cancer ResearchOncology
2011English

Selective Elimination of Mitochondria From Living Cells Induced by Inhibitors of Bioenergetic Functions

Biochemical Society Transactions
Biochemistry
2004English

Defeating EpCAM+ Liver Cancer Stem Cells by Targeting Chromatin Remodeling Enzyme CHD4 in Human Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2015English

Enhanced Immunotherapy by Combining a Vaccine With a Novel Murine GITR Ligand Fusion Protein

Oncotarget
Oncology
2017English

A Bispecific EpCAM/CD133-targeted Toxin Is Effective Against Carcinoma

Targeted Oncology
Cancer ResearchOncologyPharmacology
2013English

Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2013English

Selective Elimination of the Transformed Hepatic Stem Cells Using Hybrid Liposomes

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2011English

A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells

Neurotherapeutics
NeurologyPharmacology
2016English

Selective Elimination of Culture-Adapted Human Embryonic Stem Cells With BH3 Mimetics

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy